Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Diagnostics » Clinical Data Says PGx Business Boosts Q1 Revenue, Buys Adenosine Rx for Up to $60M

Clinical Data Says PGx Business Boosts Q1 Revenue, Buys Adenosine Rx for Up to $60M

Aug 13, 2008
Premium
Clinical Data this week announced that triple-digit growth in its pharmacogenomics unit contributed to a 39-percent increase in first-quarter revenues.
 
The news comes one week after the company announced it had acquired Adenosine Therapeutics for up to $60 million in an effort to expand its pipeline of potential therapeutic/diagnostic combination products.
 

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Another Study for AstraZeneca

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna to Seek EUA

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

To Spot it Earlier

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

PLOS Papers on Glioblastoma in Lebanon, Syndromic Gene PheWAS, Newborn Cytokine GWAS

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.

Dec
01
Featured Webinar

Post-Transplant Viral Load Monitoring: Improving Practices and Clinical Considerations

Sponsored by
Roche

Management of viral infections is critical to prevent severe morbidities and consequences in immune-suppressed transplant patients.

Dec
02
Featured Webinar

PIK3CA Mutations in Advanced Breast Cancer: The Vital Role of Tissue and Plasma Companion Diagnostics

Sponsored by
Qiagen

The Phosphoinositide 3-Kinase (PI3K) pathway is one of the most frequently altered pathways in human cancer and plays a significant role in disease progression and resistance to endocrine therapy.

Dec
15
Featured Webinar

Case Study: Deployment of High-Throughput SARS-CoV-2 Testing at UC Davis

Sponsored by
UgenTec

Diverse components of the UC Davis campus have been mobilized to deploy HTP testing to provide a safe working environment and keep the pandemic under control.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.